Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,16 USD | +6,40% | -20,30% | -69,23% |
Vakgebied
Aantal werknemers: 19
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Inhaled Dry Powder Drugs
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +48,02% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States and Australia
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +48,02% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Harlan Weisman
CEO | Chief Executive Officer | 71 | 01-12-18 |
Kirk Coleman
DFI | Director of Finance/CFO | 51 | 24-01-18 |
Zamaneh Mikhak
CTO | Chief Tech/Sci/R&D Officer | 59 | 09-01-23 |
Chief Tech/Sci/R&D Officer | - | - | |
Robert Mills
BRD | Director/Board Member | 71 | 24-01-18 |
John J. Koleng
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 52 | 01-12-18 | |
Brandi Roberts
BRD | Director/Board Member | 50 | 25-03-22 |
Thomas King
BRD | Director/Board Member | 69 | 13/12 |
Robert Mills
BRD | Director/Board Member | 71 | 24-01-18 |
Harlan Weisman
CEO | Chief Executive Officer | 71 | 01-12-18 |
Catherine C. Lee
BRD | Director/Board Member | 50 | 30/11 |
Director/Board Member | - | 30/11 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 3 098 134 | 2 981 899 ( 96,25 %) | 0 | 96,25 % |
Bedrijfsgegevens
TFF Pharmaceuticals, Inc.
1751 River Run Suite 400
76107, Fort Worth
+817 438 6168
http://www.tffpharma.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-69,23% | 6,69 mln. | |
+22,81% | 46,81 mld. | |
+47,13% | 41,29 mld. | |
-1,88% | 41,37 mld. | |
-6,20% | 28,87 mld. | |
+11,33% | 26,06 mld. | |
-21,00% | 19,13 mld. | |
-1,43% | 11,96 mld. | |
+30,73% | 12,39 mld. | |
-0,48% | 12,08 mld. |
- Beurs
- Aandelen
- Koers TFFP
- Onderneming TFF Pharmaceuticals, Inc.